Tele-genomics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Services (On-Demand Access, Genetic Assessment, Test Ordering, Expert Follow-Up), By Specialties (Cancer Genetics, Cardio Genetics, Proactive Genetics, Reproductive Genetics, Others), By End User (Patients & Their Families, Health Professionals, Health & Pharma Companies, Others), By Region, and Competition, 2020-2030F

November 2025 | 183 pages | ID: TD9C1B20798CEN
TechSci Research

Abstracts

The Global Tele-genomics Market, valued at USD 388.81 Million in 2024, is projected to experience a CAGR of 8.01% to reach USD 617.34 Million by 2030. The Global Tele-genomics Market encompasses the delivery of genetic testing, counseling, and interpretation services remotely through the integration of telemedicine and genomic analysis. This market's expansion is primarily driven by continuous advancements in telecommunication infrastructure, which facilitate seamless remote consultations and efficient data transmission. Furthermore, the rising global incidence of chronic diseases, requiring enhanced early detection and risk assessment through genetic insights, significantly fuels the demand for tele-genomics solutions.

Key Market Drivers

The increasing prevalence of chronic and genetic diseases constitutes a significant driver for the global tele-genomics market, necessitating more accessible and efficient diagnostic and counseling services. Conditions like heart disease, cancer, and diabetes, often with genetic predispositions, drive demand for early detection, risk assessment, and personalized treatment. According to the Centers for Disease Control and Prevention, in February 2024, an estimated 129 million people in the United States have at least one major chronic disease, with 42 percent affected by two or more, highlighting a substantial patient population poised for proactive genetic screening and personalized management. Tele-genomics directly addresses geographical and logistical barriers to specialized genetic services, enabling remote patient engagement vital for managing these widespread health challenges.

Key Market Challenges

The inherent complexity of data privacy concerns and the fragmented regulatory landscape across various jurisdictions represent a substantial impediment to the growth of the Global Tele-genomics Market. The highly sensitive nature of genomic information necessitates robust privacy frameworks. However, the absence of harmonized international and even intra-national regulations creates significant challenges for the secure and interoperable exchange of this critical data. This regulatory divergence complicates cross-border service delivery and hinders the establishment of standardized data sharing protocols, which are essential for large-scale genomic research and clinical application.

Key Market Trends

Two significant trends driving the global tele-genomics market are the increasing adoption of AI-powered genomic interpretation for remote consultations and the enhanced interoperability and data standardization for remote genomic platforms. Artificial intelligence is transforming the analysis of complex genomic data, making remote consultations more efficient and precise. This is evident as nearly 30% of the funding poured into healthcare startups in 2024 went to companies leveraging artificial intelligence, according to Silicon Valley Bank. Such investments underscore the growing recognition of AI's capability to process vast datasets and extract meaningful insights. AI-powered genomics has enabled precision medicine with 17.6% higher diagnostic accuracy in breast cancer detection, as reported by Forbes in September 2025. This directly translates into improved diagnostic services deliverable through tele-genomics.

Key Market Players

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

Report Scope:

In this report, the Global Tele-genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Tele-genomics Market, By Services:
• On-Demand Access
• Genetic Assessment
• Test Ordering
• Expert Follow-Up
• Tele-genomics Market, By Specialties:
• Cancer Genetics
• Cardio Genetics
• Proactive Genetics
• Reproductive Genetics
• Others
• Tele-genomics Market, By End User:
• Patients & Their Families
• Health Professionals
• Health & Pharma Companies
• Others
• Tele-genomics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Tele-genomics Market.

Available Customizations:

Global Tele-genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL TELE-GENOMICS MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Services (On-Demand Access, Genetic Assessment, Test Ordering, Expert Follow-Up)
  5.2.2. By Specialties (Cancer Genetics, Cardio Genetics, Proactive Genetics, Reproductive Genetics, Others)
  5.2.3. By End User (Patients & Their Families, Health Professionals, Health & Pharma Companies, Others)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA TELE-GENOMICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Services
  6.2.2. By Specialties
  6.2.3. By End User
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Tele-genomics Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Services
      6.3.1.2.2. By Specialties
      6.3.1.2.3. By End User
  6.3.2. Canada Tele-genomics Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Services
      6.3.2.2.2. By Specialties
      6.3.2.2.3. By End User
  6.3.3. Mexico Tele-genomics Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Services
      6.3.3.2.2. By Specialties
      6.3.3.2.3. By End User

7. EUROPE TELE-GENOMICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Services
  7.2.2. By Specialties
  7.2.3. By End User
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Tele-genomics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Services
      7.3.1.2.2. By Specialties
      7.3.1.2.3. By End User
  7.3.2. France Tele-genomics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Services
      7.3.2.2.2. By Specialties
      7.3.2.2.3. By End User
  7.3.3. United Kingdom Tele-genomics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Services
      7.3.3.2.2. By Specialties
      7.3.3.2.3. By End User
  7.3.4. Italy Tele-genomics Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Services
      7.3.4.2.2. By Specialties
      7.3.4.2.3. By End User
  7.3.5. Spain Tele-genomics Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Services
      7.3.5.2.2. By Specialties
      7.3.5.2.3. By End User

8. ASIA PACIFIC TELE-GENOMICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Services
  8.2.2. By Specialties
  8.2.3. By End User
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Tele-genomics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Services
      8.3.1.2.2. By Specialties
      8.3.1.2.3. By End User
  8.3.2. India Tele-genomics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Services
      8.3.2.2.2. By Specialties
      8.3.2.2.3. By End User
  8.3.3. Japan Tele-genomics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Services
      8.3.3.2.2. By Specialties
      8.3.3.2.3. By End User
  8.3.4. South Korea Tele-genomics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Services
      8.3.4.2.2. By Specialties
      8.3.4.2.3. By End User
  8.3.5. Australia Tele-genomics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Services
      8.3.5.2.2. By Specialties
      8.3.5.2.3. By End User

9. MIDDLE EAST & AFRICA TELE-GENOMICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Services
  9.2.2. By Specialties
  9.2.3. By End User
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Tele-genomics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Services
      9.3.1.2.2. By Specialties
      9.3.1.2.3. By End User
  9.3.2. UAE Tele-genomics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Services
      9.3.2.2.2. By Specialties
      9.3.2.2.3. By End User
  9.3.3. South Africa Tele-genomics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Services
      9.3.3.2.2. By Specialties
      9.3.3.2.3. By End User

10. SOUTH AMERICA TELE-GENOMICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Services
  10.2.2. By Specialties
  10.2.3. By End User
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Tele-genomics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Services
      10.3.1.2.2. By Specialties
      10.3.1.2.3. By End User
  10.3.2. Colombia Tele-genomics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Services
      10.3.2.2.2. By Specialties
      10.3.2.2.3. By End User
  10.3.3. Argentina Tele-genomics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Services
      10.3.3.2.2. By Specialties
      10.3.3.2.3. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL TELE-GENOMICS MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Genome Medical, Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. FDNA, Inc.
15.3. Illumina, Inc.
15.4. Informed Medical Decisions, Inc
15.5. Invitae Corporation
15.6. Pacific Radiopharmacy, Ltd.
15.7. NTP Radioisotopes SOC Ltd.
15.8. Lantheus Medical Imaging, Inc.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER